Exercise Test: Clinical Trials

5 trials of Exercise Test, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 withdrawn. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 2, Unknown 2, Withdrawn 1

Follow Exercise Test: new trials by email Literature Review of Exercise Test trials Research Report on Exercise Test

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Treatment of ARNI on Myocardial Remodeling and Progress
sacubitril/valsartan, perindopril, Cardiopulmonary Exercise Test - Myocardial Infarction
Phase 4UnknownRenJi Hospital2802020-05-012020-04-14
β-blockers Withdrawal in Patients With HFpEF and Chronotropic Incompetence: Effect on Functional Capacity (Preserve-HR)
Controlled withdrawal of beta-blockers, Cardiopulmonary Exercise Testing - Heart Failure With Normal Ejection Fraction, Chronotropic Incompetence
Phase 4CompletedFundación para la Investigación del Hospital Clínico de Valencia522018-10-012021-03-02
Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure
Sildenafil - Heart Failure
Phase 4WithdrawnUniversity of New Mexico2008-11-012023-06-26
Diagnostic Benefits of HyperQTM vs. Conventional ECG Stress Test. Comparison of HyperQ vs. Stress ECG in Women Before Angiography
Exercise test with HyperQ technology - Ischemic Heart Disease
Phase 4UnknownBSP Biological Signal Processing Ltd.2002008-08-012009-02-25
Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina
Amlodipine, iso- 5 - mononitrate, Blood tests - Myocardial Ischemia
Phase 4CompletedPfizer's Upjohn has merged with Mylan to form Viatris Inc.2002001-04-012021-01-28

Conditions studied

Myocardial Ischemia (2)  ·  Heart Failure (1)  ·  Myocardial Infarction (1)

Sponsors

BSP Biological Signal Processing Ltd. (1)  ·  Fundación para la Investigación del Hospital Clínico de Valencia (1)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1)  ·  RenJi Hospital (1)  ·  University of New Mexico (1)

Countries

China (1)  ·  Greece (1)  ·  Israel (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Dan Tzivoni, Professor (1)  ·  Joe R Anderson, PharmD (1)  ·  Jun Ma, M.D,Ph.D (1)  ·  Qin Shao, M.D,Ph.D (1)

Results publications

PMID 32073676, PMID 34794685, PMID 38324280

NIH funding

2017 (1)